Please Note: This trial is no longer enrolling new participants
A phase II study of adjuvant treatment with cisplatin-based chemotherapy plus concomitant atezolizumab in patients with stage I (tumors > 4cm), IIA, IIB, and select IIIA [T3N1-2, T4N0-2] resected non-small cell lung cancer (NSCLC) and the clearance of circulating tumor DNA (ctDNA)
| Protocol No. | CTO-BTCRC-LUN19-396 | Scope | National |
|---|---|---|---|
| Principal Investigator | Nasser Hanna | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II |
